Literature DB >> 32058817

Advancing Knowledge of Down Syndrome Brain Development and Function With Human Stem Cells.

Anita Bhattacharyya1.   

Abstract

Our bodies are made up of over 250 specific cell types, and all initially arise from stem cells during embryonic development. Stem cells have two characteristics that make them unique: (1) they are pluripotent, meaning that they can differentiate into all cell types of the body, and (2) they are capable of self-renewal to generate more of themselves and are thus able to populate an organism. Human pluripotent stem cells were first isolated from human embryos twenty years ago ( Thomson et al., 1998 ) and more recently, technology to reprogram somatic cells, such as skin and blood, to induced pluripotent stem cells has emerged ( Park et al., 2008 ; Takahashi et al., 2007 ; Yu et al., 2007 ). Induced pluripotent stem cells, or iPSCs, are particularly valuable as disease specific iPSCs can be generated from individuals with specific genetic mutations diseases. Researchers have harnessed the power of stem cells to understand many aspects of developmental biology in model organisms (e.g. worms, mice) and more recently, in humans. Human stem cells in culture recapitulate development. For example, formation of the brain occurs prenatally and follows a specific pattern of timing and cell generation. Human stem cells in the culture dish follow a similar pattern when exposed to developmental cues and can thus be used to understand aspects of prenatal human brain development that are not accessible by other means. Disease-specific iPSCs are a valuable tool to model neural development in specific neurodevelopmental disorders like Down syndrome. Down syndrome is a classic developmental disorder; mistakes that are made during development of a particular organ system result in the characteristics of the disorder. In the brain, mistakes during prenatal brain development lead to intellectual disability. Trisomy 21 (Ts21) iPSCs generated from somatic cells of Down syndrome individuals may enable us to understand the mistakes made during Down syndrome brain development.

Entities:  

Keywords:  Down syndrome; human; modeling; neurobiology; neurodevelopment; stem cells; trisomy 21

Mesh:

Year:  2020        PMID: 32058817      PMCID: PMC7169307          DOI: 10.1352/1944-7558-125.2.90

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  15 in total

1.  Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.

Authors:  Jose Luis Olmos-Serrano; Hyo Jung Kang; William A Tyler; John C Silbereis; Feng Cheng; Ying Zhu; Mihovil Pletikos; Lucija Jankovic-Rapan; Nathan P Cramer; Zygmunt Galdzicki; Joseph Goodliffe; Alan Peters; Claire Sethares; Ivana Delalle; Jeffrey A Golden; Tarik F Haydar; Nenad Sestan
Journal:  Neuron       Date:  2016-02-25       Impact factor: 17.173

2.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells.

Authors:  S C Zhang; M Wernig; I D Duncan; O Brüstle; J A Thomson
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

Review 3.  Cognitive deficits and associated neurological complications in individuals with Down's syndrome.

Authors:  Ira T Lott; Mara Dierssen
Journal:  Lancet Neurol       Date:  2010-06       Impact factor: 44.182

4.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

5.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  A human stem cell model of early Alzheimer's disease pathology in Down syndrome.

Authors:  Yichen Shi; Peter Kirwan; James Smith; Glenn MacLean; Stuart H Orkin; Frederick J Livesey
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

8.  Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.

Authors:  Aoife Murray; Audrey Letourneau; Claudia Canzonetta; Elisavet Stathaki; Stefania Gimelli; Frederique Sloan-Bena; Robert Abrehart; Pollyanna Goh; Shuhui Lim; Chiara Baldo; Franca Dagna-Bricarelli; Saad Hannan; Martin Mortensen; David Ballard; Denise Syndercombe Court; Noemi Fusaki; Mamoru Hasegawa; Trevor G Smart; Cleo Bishop; Stylianos E Antonarakis; Jürgen Groet; Dean Nizetic
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

9.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

10.  Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.

Authors:  Youssef Hibaoui; Iwona Grad; Audrey Letourneau; M Reza Sailani; Sophie Dahoun; Federico A Santoni; Stefania Gimelli; Michel Guipponi; Marie Francoise Pelte; Frédérique Béna; Stylianos E Antonarakis; Anis Feki
Journal:  EMBO Mol Med       Date:  2013-12-27       Impact factor: 12.137

View more
  1 in total

1.  Human Trisomic iPSCs from Down Syndrome Fibroblasts Manifest Mitochondrial Alterations Early during Neuronal Differentiation.

Authors:  Nunzia Mollo; Matteo Esposito; Miriam Aurilia; Roberta Scognamiglio; Rossella Accarino; Ferdinando Bonfiglio; Rita Cicatiello; Maria Charalambous; Claudio Procaccini; Teresa Micillo; Rita Genesio; Gaetano Calì; Agnese Secondo; Simona Paladino; Giuseppe Matarese; Gabriella De Vita; Anna Conti; Lucio Nitsch; Antonella Izzo
Journal:  Biology (Basel)       Date:  2021-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.